The latest closing stock price for CytomX Therapeutics as of February 21, 2025 is 0.78.
An investor who bought $1,000 worth of CytomX Therapeutics stock at the IPO in 2015 would have $-940 today, roughly -1 times their original investment - a -26.78% compound annual growth rate over 9 years.
The all-time high CytomX Therapeutics stock closing price was 34.22 on March 12, 2018.
The CytomX Therapeutics 52-week high stock price is 5.85, which is 650% above the current share price.
The CytomX Therapeutics 52-week low stock price is 0.75, which is 3.8% below the current share price.
The average CytomX Therapeutics stock price for the last 52 weeks is 1.45.
An investor who bought $1,000 worth of CytomX Therapeutics stock at the IPO in 2015 would have $-940 today, roughly -1 times their original investment - a -26.78% compound annual growth rate over 9 years.
The all-time high CytomX Therapeutics stock closing price was 34.22 on March 12, 2018.
The CytomX Therapeutics 52-week high stock price is 5.85, which is 650% above the current share price.
The CytomX Therapeutics 52-week low stock price is 0.75, which is 3.8% below the current share price.
The average CytomX Therapeutics stock price for the last 52 weeks is 1.45.